Clinical Trials Directory

Trials / Completed

CompletedNCT00585299

Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Yale University · Academic / Other
Sex
All
Age
10 Years – 21 Years
Healthy volunteers
Accepted

Summary

To assess whether reversal of fatty liver by moderate weight loss (8% of body weight) will lead to improvements in insulin sensitivity, which will be associated with changes in both glucose status and lipid profiles, in obese children and adolescents with fatty liver who have normal glucose or pre-diabetes.

Detailed description

This study will have two groups: one group that eats a moderate calorie, low-fat diet and is weighed regularly (every other week for 16 weeks) and the other who receives traditional diet therapy and returns in 16 weeks. Both groups will undergo procedures that test glucose tolerance and measure liver and muscle fat content before and after study period.

Conditions

Interventions

TypeNameDescription
OTHERLow-fat diet20% calorie from fat diet followed for 8 weeks then maintenance diet for additional 8 weeks
OTHERTraditional dietTraditional low-fat diet with dietitian follow-up in 16 weeks

Timeline

Start date
2006-10-01
Primary completion
2010-06-01
Completion
2010-09-01
First posted
2008-01-03
Last updated
2014-06-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00585299. Inclusion in this directory is not an endorsement.